Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026)

Assembly Biosciences' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 104.01% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $7.2 million (up 42.03% YoY), while the FY2025 annual figure was $6.0 million, up 7.59% from the prior year.
• Non Operating Income for Q1 2026 stood at $2.3 million, roughly flat from $2.3 million in the prior quarter.
• The five-year high for Non Operating Income was $2.3 million in Q4 2025, with the low at $71000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $1.1 million (2024), against an average of $1.1 million.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income jumped 757.75% in 2023, then sank 38.57% in 2025.
• Assembly Biosciences' Non Operating Income stood at $583000.0 in 2022, then surged by 178.22% to $1.6 million in 2023, then tumbled by 30.89% to $1.1 million in 2024, then soared by 104.37% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
• Business Quant data shows ASMB's Non Operating Income at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $1.7 million in Q3 2025.